Comparative evaluation of experimental Mycoplasma hyopneumoniae vaccines

被引：0
|
作者：
Stipkovits, L
Kadra, B
Süveges, T
Bíró, J
Schmidt, J
机构：
[1] MTA Allatorvos Tudomanyi Kutatointezete, H-1143 Budapest, Hungary
[2] CEVA Phylaxia Oltoanyag Termelo Rt, H-1107 Budapest, Hungary
来源：
MAGYAR ALLATORVOSOK LAPJA | 2005年 / 127卷 / 01期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
From two Mycoplasma hyopneumoniae strains inactivated by two different methods and using two different adjuvants 8 experimental vaccines were prepared. The experimental vaccines contained equal quantity of antigen. Three-weeks-old M. hyopneumoniae free piglets were immunized with these eight experimental vaccines and further 3 commercial vaccines used as controls. Based on clinical, bacteriological, serological and histopathological examinations, it was documented that the piglets were protected by all experimental and commercial vaccines against M. hyopneumoniae challenge.
引用
收藏
页码：13 / 20
页数：8
相关论文
共 50 条
  • [31] Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein vaccines in mice
    Chen, Austen Y.
    Fry, Scott R.
    Daggard, Grant E.
    Mukkur, Trilochan K. S.
    VACCINE, 2008, 26 (34) : 4372 - 4378
  • [32] Intradermal vaccination for Mycoplasma hyopneumoniae
    Jones, GF
    Rapp-Gabrielson, V
    Wilke, R
    Thacker, EL
    Thacker, BJ
    Gergen, L
    Sweeney, D
    Wasmoen, T
    JOURNAL OF SWINE HEALTH AND PRODUCTION, 2005, 13 (01): : 19 - 27
  • [33] Pathogenicity & virulence of Mycoplasma hyopneumoniae
    Leal Zimmer, Fernanda M. A.
    Paes, Jessica Andrade
    Zaha, Arnaldo
    Ferreira, Henrique Bunselmeyer
    VIRULENCE, 2020, 11 (01) : 1600 - 1622
  • [34] Biological properties of Mycoplasma hyopneumoniae
    Kolodziejczyk, P
    Pejsak, Z
    MEDYCYNA WETERYNARYJNA, 2004, 60 (05) : 451 - 455
  • [35] Mycoplasma hyopneumoniae management in gilts
    Pieters, Maria
    Fano, Eduardo
    VETERINARY RECORD, 2016, 178 (05)
  • [36] Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines
    Martelli, P.
    Saleri, R.
    Cavalli, V.
    De Angelis, E.
    Ferrari, L.
    Benetti, M.
    Ferrarini, G.
    Merialdi, G.
    Borghetti, P.
    VETERINARY MICROBIOLOGY, 2014, 168 (2-4) : 357 - 364
  • [37] Mycoplasma hyopneumoniae vaccination influence on porcine reproductive and respiratory syndrome virus and mycoplasma hyopneumoniae coinfection
    Silin, DS
    Lyubomska, OV
    Weng, CN
    ACTA VETERINARIA BRNO, 2001, 70 (04) : 413 - +
  • [38] Economic evaluation of national eradication and control strategies for Mycoplasma hyopneumoniae in Denmark
    Baekbo, P
    Kooij, D
    Mortensen, S
    Barfod, K
    Mousing, J
    ACTA VETERINARIA SCANDINAVICA, 1996, : 63 - 65
  • [39] A comparative pathological finding in pigs exposed to fumonisin B I and/or Mycoplasma hyopneumoniae
    Posa, Roland
    Stoev, Stoycho
    Kovacs, Melinda
    Donko, Tamas
    Repa, Imre
    Magyar, Tibor
    TOXICOLOGY AND INDUSTRIAL HEALTH, 2016, 32 (06) : 998 - 1012
  • [40] Chimeric proteins of Mycoplasma hyopneumoniae as vaccine and preclinical model for immunological evaluation
    Marcus Rebouças Santos
    Leonardo Teófilo Toledo
    Ênio José Bassi
    Wagnner José Nascimento Porto
    Gustavo Costa Bressan
    Maria Aparecida S. Moreira
    Yung-Fu Chang
    Abelardo Silva-Júnior
    Brazilian Journal of Microbiology, 2024, 55 : 943 - 953
12345